Science Explorer Back to mapMap
Discussion
Topic · Pharmacology

Cholinesterase and Neurodegenerative Diseases

Cholinesterase and Neurodegenerative Diseases is a research topic within Pharmacology. Science Explorer counts 31k research works in it since 1950. 9.9% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the pharmacology and toxicology of cholinesterase inhibitors, particularly acetylcholinesterase and butyrylcholinesterase, in the context of neurodegenerative diseases such as Alzheimer's. It explores the development of multi-target-directed ligands, novel drug therapies, and the implications for cognitive deficits. The research also delves into the structure, function, and regulation of cholinesterases, as well as their potential roles in neuroprotection and neurorestoration.

  • Cholinesterase Inhibitors
  • Acetylcholinesterase
  • Butyrylcholinesterase
  • Alzheimer's Disease
  • Neurodegenerative Diseases
  • Multi-Target-Directed Ligands
  • Pharmacology
  • Toxicology
  • Drug Development
  • Cognitive Deficits
Research works
31k
fractional, since 1950
In the world top 10%
3.1k
per year above
Top-10% rate
9.9%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+12%
the tick is no change
Largest producer
China
25% of the 10 largest, 2022-now
Cholinesterase and Neurodegenerative Diseases

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Cholinesterase and Neurodegenerative Diseases research?

By volume, China and India publish the most (829 and 800 works in 2022-now).

By volume, 2022-now

  1. 1 China 829 works
  2. 2 India 800 works
  3. 3 United States 638 works
  4. 4 Türkiye 279 works
  5. 5 Italy 153 works
  6. 6 Brazil 142 works
  7. 7 South Korea 130 works
  8. 8 Iran 122 works
  9. 9 Russia 121 works
  10. 10 Pakistan 115 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

China: 24.9%India: 24.0%United States: 19.2%Türkiye: 8.4%6 others listed: 23.5%25%largest
China829 · 24.9%India800 · 24.0%United States638 · 19.2%Türkiye279 · 8.4%6 others listed783 · 23.5%

Shares of the rows listed above, not of the whole node.

Which institutions lead Cholinesterase and Neurodegenerative Diseases research?

By volume in 2022-now, Russian Academy of Sciences publishes the most Cholinesterase and Neurodegenerative Diseases research, followed by Chinese Academy of Sciences and Harvard University.

Who are the leading researchers in Cholinesterase and Neurodegenerative Diseases?

The most-cited researchers publishing on Cholinesterase and Neurodegenerative Diseases include Jun Wang, John Q. Trojanowski and Luigi Ferrucci.

  1. 1 Jun Wang China 340k citations
  2. 2 John Q. Trojanowski United States 286k citations
  3. 3 Luigi Ferrucci United States 281k citations
  4. 4 Matthew M. Meyerson United States 280k citations
  5. 5 Wei Huang China 267k citations
  6. 6 Ben Zhong Tang China 261k citations
  7. 7 Amirhossein Sahebkar Iran 258k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Cholinesterase and Neurodegenerative Diseases?

The most cited paper in Cholinesterase and Neurodegenerative Diseases is "A new and rapid colorimetric determination of acetylcholinesterase activity" (George L. Ellman, K. Diane Courtney, Valentino Andres et al., 1961), with 27,264 citations. Next come "The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics" (14,017) and "Superoxide dismutase: Improved assays and an assay applicable to acrylamide gels" (12,959).

Most cited papers
#PaperReleasedCitations
1 A new and rapid colorimetric determination of acetylcholinesterase activity George L. Ellman, K. Diane Courtney, Valentino Andres et al. · Biochemical Pharmacology Jul 1961 27,264
2 The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics John Hardy, Dennis J. Selkoe · Science 19 Jul 2002 14,017
3 Superoxide dismutase: Improved assays and an assay applicable to acrylamide gels Charles Beauchamp, Irwin Fridovich · Analytical Biochemistry Nov 1971 12,959
4 Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families Elizabeth H. Corder, Ann M. Saunders, Warren J. Strittmatter et al. · Science 13 Aug 1993 9,582
5 Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity Elisabetta Polazzi, Ilaria Mengoni, Marco Caprini et al. · Neurosignals Open access 9 May 2012 9,018
All 99 most cited papers, with filters and sorting

Where is Cholinesterase and Neurodegenerative Diseases research done?

The largest centres of Cholinesterase and Neurodegenerative Diseases research in 2022-now are Beijing (China), Seoul (South Korea), New Delhi (India) and Moscow (Russia).

Largest cities, 2022-now

  1. 1 BeijingChina 97 works
  2. 2 SeoulSouth Korea 57 works
  3. 3 New DelhiIndia 51 works
  4. 4 MoscowRussia 46 works
  5. 5 ShanghaiChina 45 works
  6. 6 TehranIran 44 works
  7. 7 NanjingChina 43 works
  8. 8 ChennaiIndia 43 works
  9. 9 GuangzhouChina 38 works
  10. 10 RiyadhSaudi Arabia 37 works
See Cholinesterase and Neurodegenerative Diseases on the map

Where is the best place to study Cholinesterase and Neurodegenerative Diseases?

Among universities, judged by research, Harvard University, Central University of Punjab and Atatürk University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%30%mean 16.03%fractional works in this field (log) →share of work in the world top 10% →Atatürk UniversityCentral University o…Harvard UniversityBanaras Hindu Univer…
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Harvard UniversityUnited States 74.218.6%1.8×26 -2.7%
2Central University of PunjabIndia 71.624.2%39.0×13 +371.4%
3Atatürk UniversityTürkiye 69.626.0%10.5×16 -15.6%
4Banaras Hindu UniversityIndia 64.414.3%6.0×20 +48.2%
5King Saud UniversitySaudi Arabia 62.811.4%4.2×18 +85.8%
6Cairo UniversityEgypt 59.815.2%5.2×17 +74.2%
7University of FlorenceItaly 55.510.1%8.2×21 -40.9%
8China Pharmaceutical UniversityChina 52.011.3%15.5×15 +4.2%
9Chitkara UniversityIndia 51.412.0%7.5×13 +134.4%
10University College LondonUnited Kingdom 50.617.2%1.5×10 +7.6%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Cholinesterase and Neurodegenerative Diseases, country by country

Is Cholinesterase and Neurodegenerative Diseases research growing?

Output in 2022-2025 was 12% higher than in 2018-2021, peaking in 2023. The fastest-growing topics are Cholinesterase and Neurodegenerative Diseases.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Cholinesterase and Neurodegenerative Diseases as a percentage of every work published that year, 0.021% in 2024.

still counting0.020%0.040%0.060%Cholinesterase and Neurodegenerative Diseases0.019% in 202519801990200020102020

Fractional works of Cholinesterase and Neurodegenerative Diseases over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Cholinesterase and Neurodegenerative Diseases10.1% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Cholinesterase and Neurodegenerative Diseases. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.